Intangible Assets

YCBD does not appear to possess meaningful brand, patent, or regulatory-intangible protection that would let it sustain pricing power versus hemp/CBD peers, so differentiation is likely product-level rather than structurally protected.

The absence of disclosed long-run margin or ROIC evidence in the provided metrics, combined with deeply negative TTM ROIC, suggests any intangible advantage is not translating into durable economic returns versus peers.

In a category with many substitutable consumer products and private-label alternatives, intangible assets are typically easy to replicate, so YCBD’s position looks weaker than branded consumer-health peers with stronger trademark equity.

Switching Costs

YCBD’s products are likely purchased on a discretionary basis with low contractual lock-in, so customers can switch to alternative CBD/hemp offerings with minimal friction versus software or subscription peers.

The provided metrics do not indicate retention-based economics or recurring revenue stickiness, which implies switching costs are not a meaningful source of margin durability.

Compared with peers that benefit from formulations, channels, or compliance workflows that embed customers, YCBD appears to have little structural retention advantage.

Network Effects

YCBD does not show evidence of a user, data, or marketplace network that compounds value as adoption rises, so there is no visible self-reinforcing moat versus peers.

Consumer CBD demand is typically fragmented and brand-driven rather than network-driven, which limits any peer-to-peer or ecosystem flywheel.

Relative to platform businesses where scale attracts more users and suppliers, YCBD’s economics do not indicate network effects that would protect pricing or retention.

Cost Advantage

The negative TTM ROIC and ROCE imply YCBD is not converting operations into superior returns, which argues against a durable cost advantage versus peers.

Asset turnover is positive, but without evidence of structurally lower input, manufacturing, or distribution costs, that efficiency does not appear to exceed peer benchmarks in a moat-relevant way.

In a commoditized or lightly differentiated category, cost leadership is usually visible in sustained margins, and the provided data do not support that conclusion for YCBD.

Efficient Scale

YCBD does not appear to operate in a market structure where one or two firms can serve demand at lower cost than multiple rivals, so efficient-scale protection is limited versus peers.

The CBD/hemp market is generally crowded and fragmented, which reduces the likelihood that YCBD can defend share through scale-based capacity or distribution advantages.

Compared with regulated or infrastructure-like industries where scale deters entry, YCBD lacks evidence of a market position that would make competitors economically dependent on its footprint.

Overall Score

YCBD shows no clear structural moat: the available metrics point to weak returns and no evidence of switching costs, network effects, efficient scale, or durable intangible protection, leaving it materially less defensible than stronger branded or platform peers.